[HTML][HTML] Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
JA Ohar, GD Crater, A Emmett, TJ Ferro, AN Morris… - Respiratory …, 2014 - Springer
Background Inhaled long-acting beta 2 agonists used alone and in combination with an
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.
JA Ohar, GD Crater, A Emmett, TJ Ferro… - Respiratory …, 2014 - europepmc.org
Background Inhaled long-acting beta2 agonists used alone and in combination with an
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
Fluticasone propionate/salmeterol 250/50 [mu] g versus salmeterol 50 [mu] g after chronic obstructive pulmonary disease exacerbation
JA Ohar, GD Crater, A Emmett, TJ Ferro… - Respiratory …, 2014 - go.gale.com
Exacerbations are clinically important events in COPD [1], becoming more frequent and
more severe as airflow limitation worsens [2]. A frequent exacerbator phenotype …
more severe as airflow limitation worsens [2]. A frequent exacerbator phenotype …
[HTML][HTML] Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
JA Ohar, GD Crater, A Emmett… - Respiratory …, 2014 - respiratory-research.biomedcentral …
Inhaled long-acting beta2agonists used alone and in combination with an inhaled
corticosteroid reduce the risk of exacerbations in patients with stable COPD. However, the …
corticosteroid reduce the risk of exacerbations in patients with stable COPD. However, the …
[PDF][PDF] Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
JA Ohar, GD Crater, A Emmett, TJ Ferro, AN Morris… - 2014 - cyberleninka.org
Background: Inhaled long-acting beta2 agonists used alone and in combination with an
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
JA Ohar, GD Crater, A Emmett, TJ Ferro, AN Morris… - Respiratory …, 2014 - infona.pl
Background Inhaled long-acting beta2agonists used alone and in combination with an
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
[PDF][PDF] Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
JA Ohar, GD Crater, A Emmett, TJ Ferro, AN Morris… - 2014 - core.ac.uk
Background: Inhaled long-acting beta2 agonists used alone and in combination with an
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
[PDF][PDF] Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
JA Ohar, GD Crater, A Emmett, TJ Ferro, AN Morris… - 2014 - researchgate.net
Background: Inhaled long-acting beta2 agonists used alone and in combination with an
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.
JA Ohar, GD Crater, A Emmett, TJ Ferro… - Respiratory …, 2014 - search.ebscohost.com
Background: Inhaled long-acting beta< sub> 2 agonists used alone and in combination with
an inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
an inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
JA Ohar, GD Crater, A Emmett, TJ Ferro, AN Morris… - 2014 - pubmed.ncbi.nlm.nih.gov
Background Inhaled long-acting beta2 agonists used alone and in combination with an
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …
inhaled corticosteroid reduce the risk of exacerbations in patients with stable COPD …